AR021157A2 - Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]ciclohepta[1,2-b]piridina - Google Patents

Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]ciclohepta[1,2-b]piridina

Info

Publication number
AR021157A2
AR021157A2 ARP000103667A ARP000103667A AR021157A2 AR 021157 A2 AR021157 A2 AR 021157A2 AR P000103667 A ARP000103667 A AR P000103667A AR P000103667 A ARP000103667 A AR P000103667A AR 021157 A2 AR021157 A2 AR 021157A2
Authority
AR
Argentina
Prior art keywords
benzo
dcl
piperidilidin
ciclohepta
dihidro
Prior art date
Application number
ARP000103667A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22348307&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR021157(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR021157A2 publication Critical patent/AR021157A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describen composiciones farmacéuticas que contienen 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5H-benzo[5,6]-ciclohepta[1,2-b]piridina (DCL) y unacantidad protectora de DCL de una sal básica farmacéuticamente aceptable como ser fosfato dibásico decalcio y una cantidad de por lo menos un desintegrante,preferentemente dos desintegrantes como ser celulosa microcristalina y almidon suficiente para proveer una disolucion de por lo menos 80% en peso de lacomposicion farmacéutica en aproximadamente45 minutos y describe el uso de DCL para preparar una composicion farmacéutica para tratar reacciones alérgicas enmamíferos como ser el hombre.
ARP000103667A 1998-07-10 2000-07-17 Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]ciclohepta[1,2-b]piridina AR021157A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11323298A 1998-07-10 1998-07-10

Publications (1)

Publication Number Publication Date
AR021157A2 true AR021157A2 (es) 2002-06-12

Family

ID=22348307

Family Applications (4)

Application Number Title Priority Date Filing Date
ARP990103342A AR016044A1 (es) 1998-07-10 1999-07-08 Composiciones farmaceuticas que comprenden cantidades antialergenicas efectivas de descarboniletoxiloratadina
ARP000103668A AR021158A2 (es) 1998-07-10 2000-07-17 Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]-ciclohepta[1,2-b]piridina
ARP000103669A AR021159A1 (es) 1998-07-10 2000-07-17 Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]-ciclohepta[1,2-b]piridina
ARP000103667A AR021157A2 (es) 1998-07-10 2000-07-17 Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]ciclohepta[1,2-b]piridina

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ARP990103342A AR016044A1 (es) 1998-07-10 1999-07-08 Composiciones farmaceuticas que comprenden cantidades antialergenicas efectivas de descarboniletoxiloratadina
ARP000103668A AR021158A2 (es) 1998-07-10 2000-07-17 Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]-ciclohepta[1,2-b]piridina
ARP000103669A AR021159A1 (es) 1998-07-10 2000-07-17 Composiciones orales de 8-cloro-6,11-dihidro-11-(4-piperidilidin)-5h-benzo[5,6]-ciclohepta[1,2-b]piridina

Country Status (28)

Country Link
EP (3) EP1380297B1 (es)
JP (4) JP3224379B1 (es)
KR (1) KR100420641B1 (es)
CN (1) CN1145485C (es)
AR (4) AR016044A1 (es)
AT (2) ATE432075T1 (es)
AU (1) AU741201B2 (es)
BR (1) BR9910449A (es)
CA (2) CA2325014C (es)
CY (1) CY1109279T1 (es)
CZ (1) CZ300843B6 (es)
DE (2) DE69940932D1 (es)
DK (2) DK1380297T3 (es)
ES (2) ES2326214T3 (es)
HK (1) HK1030361A1 (es)
HU (1) HU228448B1 (es)
ID (1) ID28645A (es)
IL (1) IL139407A0 (es)
MY (1) MY116038A (es)
NO (1) NO331454B1 (es)
NZ (2) NZ512916A (es)
PE (1) PE20000761A1 (es)
PL (1) PL199390B1 (es)
PT (2) PT1073438E (es)
SK (1) SK288240B6 (es)
TW (1) TW575424B (es)
WO (1) WO2000002560A1 (es)
ZA (1) ZA200006224B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001045668A2 (en) 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7507714B2 (en) 2000-09-27 2009-03-24 Bayer Corporation Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use
BRPI0513417A (pt) * 2004-07-16 2008-05-06 Cipla Ltd composição farmacêutica estável, usos de um poliol, e de uma composição, processo para preparar uma composição farmacêutica, e, método para tratar uma condição responsiva à administração de uma anti-histamina
EP2181994B1 (en) 2006-03-31 2014-05-28 Research Foundation Itsuu Laboratory Antimicrobial compounds
CN101868228B (zh) 2007-11-21 2016-12-07 大日本住友制药株式会社 口腔内崩解片
TR200806298A2 (tr) 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Farmasötik formülasyon
ATE525064T1 (de) 2009-07-01 2011-10-15 Tiefenbacher Alfred E Gmbh & Co Kg Pharmazeutische zusammensetzung mit desloratadin
ES2709487T3 (es) 2010-05-10 2019-04-16 Lesvi Laboratorios Sl Formulaciones farmacéuticas estables que contienen un antihistamínico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003707A1 (en) * 1984-02-15 1985-08-29 Schering Corporation 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO AD5,6 BDCYCLOHEPTA AD1,2-b BDPYRIDINE AND ITS SALTS, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
US4657716A (en) 1984-03-19 1987-04-14 Lim Kunststoff Technologie Gesellschaft Method of making elastomeric shoe soles
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5595997A (en) 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
PE71699A1 (es) * 1997-02-07 1999-08-03 Sepracor Inc Composicion farmaceutica de descarboetoxiloratadina sin lactosa, no higroscopica y anhidra

Also Published As

Publication number Publication date
ATE432075T1 (de) 2009-06-15
JP2010265329A (ja) 2010-11-25
JP4160739B2 (ja) 2008-10-08
DK1073438T3 (da) 2004-05-10
ZA200006224B (en) 2001-11-01
CZ20004056A3 (cs) 2001-03-14
EP1073438A1 (en) 2001-02-07
JP3224379B1 (ja) 2001-10-29
EP1073438B1 (en) 2004-03-31
KR20010043402A (ko) 2001-05-25
AU741201B2 (en) 2001-11-22
CN1145485C (zh) 2004-04-14
NZ512916A (en) 2003-03-28
NO20005485L (no) 2001-03-09
CA2377178A1 (en) 2000-01-20
PT1380297E (pt) 2009-07-06
ATE262904T1 (de) 2004-04-15
IL139407A0 (en) 2001-11-25
TW575424B (en) 2004-02-11
NO20005485D0 (no) 2000-10-31
ID28645A (id) 2001-06-21
PL344045A1 (en) 2001-09-24
NZ507885A (en) 2001-08-31
JP2002068983A (ja) 2002-03-08
JP2005298524A (ja) 2005-10-27
AU4953199A (en) 2000-02-01
WO2000002560A1 (en) 2000-01-20
PL199390B1 (pl) 2008-09-30
CN1303284A (zh) 2001-07-11
EP1380297B1 (en) 2009-05-27
HUP0101900A2 (hu) 2001-11-28
AR021159A1 (es) 2002-06-12
CZ300843B6 (cs) 2009-08-26
EP2055303A2 (en) 2009-05-06
CA2325014A1 (en) 2000-01-20
PE20000761A1 (es) 2000-08-31
SK288240B6 (sk) 2015-02-03
DE69916042D1 (de) 2004-05-06
HUP0101900A3 (en) 2003-01-28
DE69916042T2 (de) 2004-11-11
HU228448B1 (en) 2013-03-28
DE69940932D1 (de) 2009-07-09
KR100420641B1 (ko) 2004-03-02
MY116038A (en) 2003-10-31
AR016044A1 (es) 2001-06-20
EP2055303A3 (en) 2009-12-16
EP1380297A1 (en) 2004-01-14
CA2325014C (en) 2002-05-28
SK17112000A3 (sk) 2001-12-03
PT1073438E (pt) 2004-07-30
JP4621082B2 (ja) 2011-01-26
DK1380297T3 (da) 2009-08-17
CY1109279T1 (el) 2012-05-23
JP2002520285A (ja) 2002-07-09
BR9910449A (pt) 2001-01-02
ES2326214T3 (es) 2009-10-05
AR021158A2 (es) 2002-06-12
ES2214871T3 (es) 2004-09-16
IL139407A (en) 2001-10-31
NO331454B1 (no) 2012-01-09
HK1030361A1 (en) 2001-05-04

Similar Documents

Publication Publication Date Title
CY1109279T1 (el) Στοματικες συνθεσεις με βαση την 8-chloro-6,11-dihydro-11-(4-piperidylidene) -5h-benzo[5,6]-cyclo-hepta[1,2-b]pyridine
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
ME00298B (me) Farmaceutski preparat
NO179250C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktiv (+)--(2,3-dimetoksyfenyl)-1-[2-(4-fluorfenyl)etylÅ-4-piperidinmetanol
SE9704870D0 (sv) New pharmaceutical formulation I
ATE284861T1 (de) N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden
LU91751I2 (fr) Asenapin et ses dérivés pharmaceutiquement acceptables (SYCREST®)
SE9301171D0 (sv) Pharmaceutical composition containing lipophilic drugs
FI943727A (fi) Piperidinyylitiasyklisiä johdannaisia
NO963731L (no) Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
HUP0203320A3 (en) Indolylpiperidine derivatives and their use as antihistaminic and antiallergic agents, process for their preparation, pharmaceutical compositions containing them
DE69632194D1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
AU1262501A (en) Compositions for transdermal and transmucosal administration of therapeutic agents
NZ501417A (en) Crystalline polymorphs of descarbonylethoxyloratadine (8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta[1,2-b]pyridine) and methods for their use
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
EE04058B1 (et) Benso[c]kinolisiini derivaadid, nende valmistamine ja kasutamine 5a-reduktaasi inhibiitoritena
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
TR200200683T2 (tr) Oral kontrollü salıverme formülasyonları.
NO20006547L (no) Salter av paroxetine
ECSP993054A (es) COMPOSICIONES ORALES DE 8- CLORO- 6,11 - DIHIDRO- 11- (4- PIPERIDILIDIN)- 5H- BENZO [5,6] CICLOHEPTA [1,2 - b] PIRIDINA (CASO PD0885K)
DE60217315D1 (de) Pharmazeutische zusammensetzungen von rapamycines
MX9303443A (es) Alquiliden-hidroxilaminas azaciclicas y azabiciclicas, proceso para su preparacion y composiciones farmaceuticas que las contienen.
HUP0000307A2 (hu) Y Neuropeptid antagonisták és ezeket tartalmazó gyógyászati készítmények
PT986390E (pt) Composicoes farmaceuticas que contem cicloridrato de cinchonina

Legal Events

Date Code Title Description
FB Suspension of granting procedure